Financials

  • Market Capitalization 443.75 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.53
Rapporto prezzo/fatturato
8.08

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3008
SLN
Silence Therapeutics Plc - American Depository Share
9.63 USD+3.66%-8.20%+41.83%+52.37%454.87 M USD
3010
VALN
Valneva SE - American Depositary Shares
5.22 USD-0.76%-2.61%-4.57%-20.06%452.94 M USD
3015
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
7.55 USD+5.59%-3.21%+15.09%-19.68%466.23 M USD
3037
CCCC
C4 Therapeutics, Inc. - Common Stock
3.89 USD-0.77%-10.37%-2.26%+63.45%430.11 M USD